Stellus Capital Investment Corp
NYSE:SCM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11.4935
15.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Q2-2025 Earnings Call
AI Summary
Earnings Call on Aug 7, 2025
Net Investment Income: Stellus reported $0.34 per share of net investment income for the quarter, below the $0.40 per share dividend declared.
Dividend Coverage: The company is using spillover income, which stands at just under $45 million for 2025 and is expected to be about $38 million in 2026, to help fund the dividend.
Portfolio Growth: Stellus' portfolio reached approximately $1 billion across 113 companies, with $26 million in new fundings since quarter end and expectations to maintain this level by quarter's end.
Credit Quality: Asset quality remains stable, with 84% of the portfolio meeting or exceeding plan and nonaccrual loans at 3.8% of fair value, down from last quarter.
SBIC License Progress: The company received a greenlight letter for its SBIC III license and expects roughly half its deal flow to qualify, supporting future growth.
Equity Realizations: Management anticipates around $12 million in equity realization proceeds and $10 million of gains in the back half of 2025, with high confidence in closings.
Pipeline Activity: M&A and investment activity have picked up meaningfully since July, with a robust actionable pipeline and increased opportunities from private equity partners.
While current net investment income per share does not fully cover the dividend, Stellus is funding the gap with spillover income. The company has just under $45 million of spillover for 2025 and expects about $38 million in 2026, gradually using this reserve to support the dividend distribution.
The investment portfolio grew to roughly $1 billion across 113 companies, its highest ever. Stellus invested $26 million in new fundings since June 30 and expects portfolio size to remain steady through the end of the quarter. Management highlights increased M&A activity and a robust pipeline, with 10 highly actionable opportunities at any time and 5–7 new leads per week.
Asset quality is described as slightly better than planned, with 84% of assets rated on or ahead of plan and nonaccrual loans dropping to 3.8% of fair value, covering five companies. No new loans were added to nonaccrual this quarter. Management expects to recover principal and income on assets rated ‘3’ and believes current issues are manageable, with supportive private equity sponsors.
The company received a greenlight letter for its SBIC III license and expects to receive the license, which should enable further leverage for qualifying investments. Historically, about half of the deal flow qualifies for SBIC funding. Current leverage is about 0.9x regulatory (targeted at 1:1) and 1.7x total for GAAP, with room to expand the portfolio by $50–$75 million over time as new capital is drawn.
Stellus expects around $12 million in equity realization proceeds in the second half of 2025, with an anticipated $10 million in gains. Management expresses high confidence in these outcomes, noting that all targeted businesses are actively marketed and performing well, though some timing uncertainty is acknowledged.
The company declared a third quarter dividend of $0.40 per share, payable monthly, and expects to maintain this rate in the fourth quarter, subject to board approval. Dividend policy continues to balance current income with spillover reserves.
Management notes a significant increase in M&A and investment activity since July, attributed to reduced noise around tariffs and greater engagement among private equity partners. The actionable deal pipeline is robust, and repayments are expected to accelerate, supporting ongoing portfolio growth despite competitive conditions.
Good morning, ladies and gentlemen, and thank you for standing by. At this time, I would like to welcome everyone to Stellus Capital Investment Corporation's conference call to report financial results for its second fiscal quarter ended June 30, 2025. [Operator Instructions]
As a reminder, this conference is being recorded today, August 7, 2025. It is now my pleasure to turn the floor over to Mr. Robert Ladd, Chief Executive Officer of Stellus Capital Investment Corporation. Mr. Ladd, you may begin your conference.
Yes. Thank you, Ali. Good morning, everyone, and thank you for joining our call. Welcome to our conference call covering the quarter ended June 30, 2025. Joining me this morning is Todd Huskinson, our Chief Financial Officer, who will cover important information about forward-looking statements as well as an overview of our financial information.
Thank you, Rob. I'd like to remind everyone that today's call is being recorded. Please note that this call is the property of Stellus Capital Investment Corporation and that any unauthorized broadcast of this call in any form is strictly prohibited. Audio replay of the call will be available by using the telephone number and PIN provided in our press release announcing this call.
I'd also like to turn your attention to the customary safe harbor disclosure in our press release regarding forward-looking information. Today's conference call may also include forward-looking statements and projections, and we ask that you refer to our most recent filing with the SEC for important factors that could cause actual results to differ materially from these projections.
We will not update any forward-looking statements unless required by law. To obtain copies of our latest SEC filings, please visit our website at www.stelluscapital.com under the Public Investors link or call us at 713-292-5400.
Now I'll cover operating results for the quarter, but I would like to start with our life-to-date activity. Since our IPO in November 2012, we've invested approximately $2.7 billion in over 210 companies and received approximately $1.7 billion of repayments while maintaining stable asset quality.
We've paid $306 million of dividends to our investors, which represents $17.35 per share to an investor in our IPO in November 2012, which was offered at $15 per share.
Turning now to the quarterly operating results. In the second quarter, we generated $0.34 per share of GAAP net investment income and core net investment income was $0.35 per share, which excludes estimated excise taxes. Net asset value per share decreased $0.04 during the quarter due to the reduction in spillover income.
During the quarter, we issued approximately 300,000 shares for $3.9 million of proceeds under our ATM program. Year-to-date, we've issued approximately 900,000 shares for $13.2 million, and all issuances were above net asset value.
Turning to portfolio and asset quality. We ended the quarter with an investment portfolio at fair value of $985.9 million across 112 portfolio companies, slightly down from $991 million across 110 companies as of March 31, 2025. During the second quarter, we invested $15.4 million in 3 new portfolio companies that had $7.4 million in other investment activity at par.
We also received two full repayments totaling $21.7 million, one equity realization totaling $500,000, which resulted in a realized gain of $200,000 and we received $10.4 million of other repayments, all at par. At June 30, 98% of our loans were secured and 91% were priced at floating rates. The average loan for company is $9.2 million and the largest overall investment is $21.2 million, both at fair value. All but one of our portfolio companies are backed by a private equity firm.
Overall, our asset quality is slightly better than planned. At fair value, 84% of our portfolio is rated a 1 or a 2 or on or ahead of plan and 16% of the portfolio is marked at an investment category of 3 or below, meaning not meeting plan or expectations. We did not add any new loans to our nonaccrual list during the quarter.
Currently, we have loans to 5 portfolio companies on nonaccrual, which comprised 6.8% of the total cost and 3.8% of the fair value of the total loan portfolio, respectively, which represents a decrease from the prior quarter.
With respect to capital, as a reminder, we've received a greenlight letter from the Small Business Administration for Stellus Capital SBIC III. This is an important step in the process, and we, therefore, expect to receive a license, although it's not guaranteed.
In general, as our existing debentures are repaid, we intend to draw new leverage under the SBIC III license to continue funding qualifying portfolio company investments.
And with that, I'll turn it back over to Rob to discuss the overall outlook.
Okay. Thank you, Todd. As we look ahead of the third quarter of 2025, I'll cover portfolio growth, equity realizations and dividends.
Investment activity has picked up meaningfully over the past 30 days or so. We expect the second half of the year to be busy as evidenced by the $26 million of new fundings since June 30. Our portfolio now stands at approximately $1 billion with 113 companies, now our largest number. And based on new fundings and repayments, we should end the quarter at about the same level.
With M&A activity picking up, we expect to see more equity realizations over the next 5 months. Our best estimate today is $12 million of proceeds and approximately $10 million of gains.
Finally, regarding dividends, we declared the dividend for the third quarter of $0.40 per share payable monthly. We expect the fourth quarter to also be payable at this $0.40 per share rate for the quarter, again, payable monthly, of course, subject to Board approval.
And with that, we'll open up for questions. And Ali, you may begin the question-and-answer session, please.
[Operator Instructions]
Our first question is coming from Christopher Nolan with Ladenburg Thalmann.
The EPS is not covering the dividend for the last few quarters. Two questions. How much spillover is there left over? And what's the strategy in terms of increasing your leverage to cover the dividend?
Yes, Todd, why don't you cover the spillover and then I'll cover the question about leverage.
Okay. Yes, sounds good, Rob. So with respect to spillover, so this year, we have just under $45 million of spillover that we are working off through the dividend. And then going into next year, for next year's amount, we expect it to be about $38 million, and we'll continue to kind of reduce it from there. So that's what we're working on with respect to the dividend.
And then, Chris, relative to use of leverage. So we're currently running at about 0.9x on a regulatory test and total leverage for GAAP of about 1.7x. Our target leverage, we've stated for a good while is about 1:1 on the regulatory test. So we don't intend to change that in the near term. So we have the capacity to move leverage up through the use of our bank facility. We expect that we have the capital base to really take the portfolio what is currently about $1 billion, up $50 million to $75 million higher over time. Is that helpful?
Yes, it is. And just as a quick follow-up. For the SBIC III license, how much of your deal flow is eligible for the SBIC? And how quickly do you think you can fill that?
Yes. So interestingly, historically, roughly half of what we look at qualifies. So it's a meaningful part of our deal flow and an important aspect of the company.
So you can ramp that up pretty quick order, I'd imagine.
Yes. So this is helpful for us, and we anticipate we'll be able to get it approved as Todd indicated.
Our next question is coming from Erik Zwick with Lucid Capital Markets.
This is Justin on for Erik today. Rob, just going off your comments, obviously, good momentum to start the quarter with some sizable new investments. Just curious how the pipeline is looking for the remainder of the year and where you're seeing opportunities, whether that's new or add-on investments.
Yes. So again, as I indicated, quite a pickup in M&A activity. It looked like it started to happen after July 4. The -- I guess, the noise around the tariffs has quieted some, although there's more in the news in the last couple of days. But I think that certainly, private equity firms with whom we work exclusively are much more active in the marketplace looking at opportunities. So things have picked up meaningfully.
So again, we would expect and our pipeline runs typically, I'd say, 10 opportunities at a time that are very actionable, and we see 5 to 7 new opportunities a week. So we're very busy, but also very selective. So I do think we've got the ability to continue to grow here. And as indicated, we have the capital to grow as well. As part of that, though, of course, we would expect repayments to speed up, which have been slower this year. But we think, notwithstanding the repayments expected, we'll be able to grow the portfolio between now and the end of the calendar year.
Okay. That's great. And then just a follow-up on credit quality. I know you guys can't disclose much given the private aspect of all your portfolio companies. But any insight into any potential resolutions or progress that's being made with the current nonaccrual list?
Yes. The -- and thanks for noting the privacy aspect. Continue to work through them, all have private equity firms associated with them, backing them. So we'll need more time. But fortunately, this quarter, as Todd noted, we had no new nonaccruals. So I think they'll all take more time, but I think generally in a good spot and where necessary, we'll get more involved in the situation to make sure the company continues. But our experience has been good private equity firms who we deal with typically put money and new money in a couple of times to support their businesses. So these are ones working through that system, if you will.
Our next question is coming from Robert Dodd with Raymond James.
On the potential equity realizations that I think you mentioned, maybe $12 million in proceeds, $10 million in gains in the second half of the year. What's the level of confidence on that? Because I mean, it does -- if the market activity has picked up, but who knows, like I mean, how high is the confidence level on realizing them this year? I mean, if they don't get realized this year, then it just happens later. But what's -- kind of how is your feeling on the certainty of those things actually happening this year?
Sure. Sure, Robert. Yes, it's a great question. So when we indicate and forecast, again, things can change. Those are businesses that are in the market being marketed, some further along than others, but all are being actively marketed by a banker or by a company. So we would -- and all are well-performing businesses. So we think the likelihood would be high.
And sometimes things don't happen. But -- and also, there could be things that we're not aware of, especially if we're just in an equity-only position, don't have the debt instrument anymore. But we say fairly high, again, based on active marketing by the companies.
Got it. Got it. And then if I can go to the -- not so much the nonaccrual side, but the 15% of the portfolio is rated 3 or lower, i.e., not meeting plan. I mean if we exclude the nonaccruals because those have obviously already are having their issues currently, what -- how much of the remainder of that are you seriously nervous about versus -- yes, it's not meeting plan, but we're not that worried kind of thing?
Given its category of being a 3, by definition, it means that we expect to receive all of our principal and all of the associated income to be a 4, it would be we don't expect to receive the income and 5 to be we don't expect the income or all of the principal. So our current thinking is, by definition, we expect to receive all principal and income. That would be the best way to characterize it, I think, Robert.
Okay. I appreciate that. And then if I can, one more, just on that, just kind of -- like you said, and you kind of partly addressed it, activity picked up after July 4 and meaningfully over the last 30 days. I mean, on the time frame because obviously, some businesses take longer to do diligence than others. What -- you said you expect to still grow the portfolio by year-end. But how much uncertainty is in that given the pipeline and kind of the timing of where we are with 4 months left in the year and these processes ramping up now. And I'm not talking about the equity kind of the pipeline.
Sure, sure. So the pipeline, as indicated earlier, is quite robust. So a number of opportunities that are in what we would describe as a 75% or higher probability. So a lot in that bucket. And then a lot of things that we're looking at that given that we're here in August, all of which have a good chance if they move forward, and we're selected to certainly close by the fourth quarter. So again, it's hard to predict these things on both ends. We have found that repayments sometimes happen more quickly than new fundings, but we expect we'll have both and can grow the portfolio the balance of the year.
As we currently have no further questions on the lines at this time, I would like to hand the call back over to Mr. Ladd for any closing remarks.
Okay. Thank you very much, and thank you, everyone, for being on the call today and your support of our company, and we look forward to providing the update on our third quarter results, which will be in early November. Take care.
Thank you, ladies and gentlemen. This does conclude today's call. You may disconnect your lines at this time, and have a wonderful day. And we thank you for your participation.